Duke University is ranked 8th in research and development expenditures, with more than $1.1 billion in funding. A majority of that funding, specifically $950 million of it, goes directly to Life Science research.
Key Stats:
The Consortium for HIV/AIDS Vaccine Development at Duke University was awarded $26.3M in 2019, from the National Institute of Allergy and Infectious Diseases, to develop a successful HIV vaccine design. The program has received $47.3M in funding since 2019.
The Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery at Duke University received over $28 million in 2018 from NIH, $204.7 million total since 2012. The Center is aimed at finding a cure for HIV/AIDS.
Duke received $15 million in 2020 from NIAID for the Antibacteria Resistance Leadership Group (ARLG), which will design and implement research into mitigating bacteria resistance factors. ARLG has received over $88 million from NIAID since 2013.
“I am impressed at the good turn out and quality leads that this show has generated. The researchers were engaging and interested in my products and services. Equally impressed with the event staff. They go out of their way to assist you with anything.” - S. C., Exhibitor, Duke University BCI event
Duke Scientific Sales and Networking Opportunities
We invite you to join other top lab suppliers in bringing the best new tools and technologies to Durham-area researchers at the Duke University BioResearch Product Faire™ events.
